KCTD13 Antikörper (N-Term)
Kurzübersicht für KCTD13 Antikörper (N-Term) (ABIN633662)
Target
Alle KCTD13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- KCTD13 antibody was raised against the N terminal of KCTD13
-
Aufreinigung
- Affinity purified
-
Immunogen
- KCTD13 antibody was raised using the N terminal of KCTD13 corresponding to a region with amino acids PGPAAYGLKPLTPNSKYVKLNVGGSLHYTTLRTLTGQDTMLKAMFSGRVE
-
-
-
-
Applikationshinweise
-
WB: 0.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
KCTD13 Blocking Peptide, (ABIN5614303), is also available for use as a blocking control in assays to test for specificity of this KCTD13 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KCTD13 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- KCTD13 (Potassium Channel Tetramerisation Domain Containing 13 (KCTD13))
-
Andere Bezeichnung
- KCTD13
-
Hintergrund
- KCTD13 mRNA is expressed in 3T3-L1 adipocytes and THP-1 macrophages. It is suggested that this gene provides a link between cytokine activation and DNA replication in liver as well as in other tissues.
-
Molekulargewicht
- 36 kDa (MW of target protein)
Target
-